Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease Assessedthrough Validated Fibrosis Scores

D. Gonzalez, A. I. Blanco, Óscar Moreno Domínguez, Isabel Calvo Viñuelas
{"title":"Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease Assessedthrough Validated Fibrosis Scores","authors":"D. Gonzalez, A. I. Blanco, Óscar Moreno Domínguez, Isabel Calvo Viñuelas","doi":"10.4172/2167-0889.1000209","DOIUrl":null,"url":null,"abstract":"Introduction Nonalcoholic fatty liver disease (NAFLD) is common among morbid obese (MO) with estimated prevalence of 90%. Weight loss (WL) play a main role in its control. Objective To determine the evolution of NAFLD by means of validated fibrosis scores 12 months after bariatric surgery (BS) and measure its impact. Methods Retrospective observational study which enrolled MO who underwent BS at a University Hospital in Madrid, Spain during 2014 and 2015. Patients features were collected at baseline and compared at 12 months after BS. NAFLD fibrosis and FIB-4 scores were calculated. Results 50 patients (37 women, 74%), mean age 44 ± 12 years. At baseline, mean weight was 124.98 ± 19.88 kg, Body Mass Index (BMI) 45.74 ± 5.93 kg/m2, Basal Glycaemia (BG) 104 ± 25 mg/dL, glycated hemoglobin (HbA1c) 5.9 ± 0.8%, alanine aminotransferase (ALT) 27 (12-125) IU, aspartate aminotransferase (AST) 22 (11-126) IU, gamma glutamyl transpeptidase (GGT) 35 (7-216) IU, alkaline phosphatase (AP) 72 (17-159) IU. NAFLD fibrosis and FIB-4 scores were 1.859 (-1.755-4.631) and 0.72 (0.22-3.05), respectively. In the postoperative period, mean weight was 84.17 ± 15.93 kg, BMI 30.76 ± 4.52 kg/m2, BG 85 ± 12 mg/dL, HbA1c 5.3 ± 0.31%, ALT 20 (9-133) IU, AST 20 (11-80) IU, GGT 18 (6-237) IU, AP 75 (8-183) IU. NAFLD fibrosis and FIB-4 scores were 0.412 (-2.643- 4.661) and 0.78 (0.38-1.79), respectively. Mean WL was 40.75 ± 14.59 kg, mean percentage of excess WL after BS was 73.23 ± 20.79%, and mean percentage of excess BMI loss was 72.92 ± 19.36%. Weight, BMI, BG, HbA1c, ALT, GGT, total cholesterol and triglycerides significantly improved after BS, as well as type 2 diabetes, hypertension and dyslipidemia whose prevalence declined. NAFLD fibrosis score significantly decrease after BS, but FIB-4 did not. These two scores were strongly correlated between them. Conclusions BS is an effective intervention to control the progression of NAFLD evaluated through clinical parameters, analytical values and fibrosis scores, of which NAFLD score is better than FIB-4 index.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"2021 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Liver","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-0889.1000209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Nonalcoholic fatty liver disease (NAFLD) is common among morbid obese (MO) with estimated prevalence of 90%. Weight loss (WL) play a main role in its control. Objective To determine the evolution of NAFLD by means of validated fibrosis scores 12 months after bariatric surgery (BS) and measure its impact. Methods Retrospective observational study which enrolled MO who underwent BS at a University Hospital in Madrid, Spain during 2014 and 2015. Patients features were collected at baseline and compared at 12 months after BS. NAFLD fibrosis and FIB-4 scores were calculated. Results 50 patients (37 women, 74%), mean age 44 ± 12 years. At baseline, mean weight was 124.98 ± 19.88 kg, Body Mass Index (BMI) 45.74 ± 5.93 kg/m2, Basal Glycaemia (BG) 104 ± 25 mg/dL, glycated hemoglobin (HbA1c) 5.9 ± 0.8%, alanine aminotransferase (ALT) 27 (12-125) IU, aspartate aminotransferase (AST) 22 (11-126) IU, gamma glutamyl transpeptidase (GGT) 35 (7-216) IU, alkaline phosphatase (AP) 72 (17-159) IU. NAFLD fibrosis and FIB-4 scores were 1.859 (-1.755-4.631) and 0.72 (0.22-3.05), respectively. In the postoperative period, mean weight was 84.17 ± 15.93 kg, BMI 30.76 ± 4.52 kg/m2, BG 85 ± 12 mg/dL, HbA1c 5.3 ± 0.31%, ALT 20 (9-133) IU, AST 20 (11-80) IU, GGT 18 (6-237) IU, AP 75 (8-183) IU. NAFLD fibrosis and FIB-4 scores were 0.412 (-2.643- 4.661) and 0.78 (0.38-1.79), respectively. Mean WL was 40.75 ± 14.59 kg, mean percentage of excess WL after BS was 73.23 ± 20.79%, and mean percentage of excess BMI loss was 72.92 ± 19.36%. Weight, BMI, BG, HbA1c, ALT, GGT, total cholesterol and triglycerides significantly improved after BS, as well as type 2 diabetes, hypertension and dyslipidemia whose prevalence declined. NAFLD fibrosis score significantly decrease after BS, but FIB-4 did not. These two scores were strongly correlated between them. Conclusions BS is an effective intervention to control the progression of NAFLD evaluated through clinical parameters, analytical values and fibrosis scores, of which NAFLD score is better than FIB-4 index.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过纤维化评分评估减肥手术对非酒精性脂肪性肝病的影响
非酒精性脂肪性肝病(NAFLD)在病态肥胖(MO)中很常见,估计患病率为90%。减肥(WL)在其控制中起主要作用。目的通过减肥手术(BS)后12个月的纤维化评分来确定NAFLD的演变并衡量其影响。方法回顾性观察研究纳入2014 - 2015年在西班牙马德里某大学医院接受BS治疗的MO患者。在基线时收集患者特征,并在BS后12个月进行比较。计算NAFLD纤维化和FIB-4评分。结果50例患者(女性37例,占74%),平均年龄44±12岁。基线时,平均体重为124.98±19.88 kg,体重指数(BMI) 45.74±5.93 kg/m2,基础血糖(BG) 104±25 mg/dL,糖化血红蛋白(HbA1c) 5.9±0.8%,丙氨酸转氨酶(ALT) 27 (12-125) IU,天冬氨酸转氨酶(AST) 22 (11-126) IU,谷氨酰转肽酶(GGT) 35 (7-216) IU,碱性磷酸酶(AP) 72 (17-159) IU。NAFLD纤维化和FIB-4评分分别为1.859(-1.75 -4.631)和0.72(0.22-3.05)。术后平均体重84.17±15.93 kg, BMI 30.76±4.52 kg/m2, BG 85±12 mg/dL, HbA1c 5.3±0.31%,ALT 20 (9-133) IU, AST 20 (11-80) IU, GGT 18 (6-237) IU, AP 75 (8-183) IU。NAFLD纤维化和FIB-4评分分别为0.412(-2.643- 4.661)和0.78(0.38-1.79)。平均体重为40.75±14.59 kg,减重后平均体重超标率为73.23±20.79%,平均体重超标率为72.92±19.36%。BS后体重、BMI、BG、HbA1c、ALT、GGT、总胆固醇、甘油三酯明显改善,2型糖尿病、高血压、血脂异常患病率下降。BS后NAFLD纤维化评分明显降低,FIB-4评分无明显差异。这两个分数之间有很强的相关性。结论通过临床参数、分析值和纤维化评分评价,BS是控制NAFLD进展的有效干预措施,其中NAFLD评分优于FIB-4指数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Review on Frailty in Patient with Liver Cirrhosis and Its Management Recent and Novel Observations Pertaining to Non-Infectious Liver Disorders Editor's Note on Liver Journal Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update Spontaneous Fungal Peritonitis in Patients with Liver Cirrhosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1